{"entity":{"type":"insider","cik":"0001534002","url":"/insider/0001534002","json_url":"/insider/0001534002.json","name":"Russell Angus C.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2013-06-18","last":"2021-12-15","span_basis":"filed_date"},"name_variants":[{"name":"Russell Angus C.","source":"filing","n_filings":10,"first_seen":"2013-06-18","last_seen":"2021-12-15"}],"transactions":[{"id":5183284,"accession":"0001479290-21-000173","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001479290-21-000173","line_url":"/filing/0001479290-21-000173#line-1","is_derivative":false,"issuer_cik":"0001479290","issuer_name":"Revance Therapeutics, Inc.","issuer_ticker":"RVNC","issuer_name_source":null,"issuer_url":"/issuer/0001479290","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6400.0,"shares_display":"6,400","price_per_share":15.7408,"price_display":"15.74","price_state":"stated","total_value":100741.12,"total_display":"100,741.12","total_whole":"100,741","shares_owned_after":26913.0,"shares_owned_after_display":"26,913","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-13","filed_date":"2021-12-15","scope":"insider"},{"id":5414962,"accession":"0001493152-21-015786","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-015786","line_url":"/filing/0001493152-21-015786#line-2","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"Lineage Cell Therapeutics, Inc.","issuer_ticker":"LCTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, no par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4720.0,"shares_display":"4,720","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":14018.4,"total_display":"14,018.40","total_whole":"14,018","shares_owned_after":87500.0,"shares_owned_after_display":"87,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-06-30","scope":"insider"},{"id":2387756,"accession":"0000950138-20-000467","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950138-20-000467","line_url":"/filing/0000950138-20-000467#line-1","is_derivative":false,"issuer_cik":"0001534002","issuer_name":"Mallinckrodt plc","issuer_ticker":"MNKKQ","issuer_name_source":null,"issuer_url":"/issuer/0001534002","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51789.0,"shares_display":"51,789","price_per_share":0.1287,"price_display":"0.13","price_state":"stated","total_value":6665.2443,"total_display":"6,665.24","total_whole":"6,665","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-16","scope":"insider"},{"id":7957205,"accession":"0001387131-19-006399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-006399","line_url":"/filing/0001387131-19-006399#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":27700.0,"total_display":"27,700.00","total_whole":"27,700","shares_owned_after":93500.0,"shares_owned_after_display":"93,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-26","scope":"insider"},{"id":7957203,"accession":"0001387131-19-006191","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001387131-19-006191","line_url":"/filing/0001387131-19-006191#line-2","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.99,"price_display":"2.99","price_state":"stated","total_value":29900.0,"total_display":"29,900.00","total_whole":"29,900","shares_owned_after":83500.0,"shares_owned_after_display":"83,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-15","filed_date":"2019-08-15","scope":"insider"},{"id":7957201,"accession":"0001387131-19-006191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-19-006191","line_url":"/filing/0001387131-19-006191#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.76,"price_display":"2.76","price_state":"stated","total_value":69000.0,"total_display":"69,000.00","total_whole":"69,000","shares_owned_after":73500.0,"shares_owned_after_display":"73,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-15","scope":"insider"},{"id":8649421,"accession":"0001209191-15-079470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-079470","line_url":"/filing/0001209191-15-079470#line-1","is_derivative":false,"issuer_cik":"0000876343","issuer_name":"BIOTIME INC","issuer_ticker":"BTX","issuer_name_source":null,"issuer_url":"/issuer/0000876343","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares, no par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":3.83,"price_display":"3.83","price_state":"stated","total_value":191500.0,"total_display":"191,500.00","total_whole":"191,500","shares_owned_after":67500.0,"shares_owned_after_display":"67,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-06","filed_date":"2015-11-10","scope":"insider"},{"id":8194413,"accession":"0001387131-15-002666","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-002666","line_url":"/filing/0001387131-15-002666#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13500.0,"shares_display":"13,500","price_per_share":5.984,"price_display":"5.98","price_state":"stated","total_value":80784.0,"total_display":"80,784.00","total_whole":"80,784","shares_owned_after":48500.0,"shares_owned_after_display":"48,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-25","filed_date":"2015-08-27","scope":"insider"},{"id":8890646,"accession":"0001387131-15-001641","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-15-001641","line_url":"/filing/0001387131-15-001641#line-1","is_derivative":false,"issuer_cik":"0000025743","issuer_name":"TherapeuticsMD, Inc.","issuer_ticker":"TXMD","issuer_name_source":null,"issuer_url":"/issuer/0000025743","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":35000.0,"shares_display":"35,000","price_per_share":6.1519,"price_display":"6.15","price_state":"stated","total_value":215316.5,"total_display":"215,316.50","total_whole":"215,317","shares_owned_after":35000.0,"shares_owned_after_display":"35,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-12","filed_date":"2015-05-13","scope":"insider"},{"id":5306774,"accession":"0001209191-13-042231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-042231","line_url":"/filing/0001209191-13-042231#line-2","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4950.0,"shares_display":"4,950","price_per_share":14.3696,"price_display":"14.37","price_state":"stated","total_value":71129.52,"total_display":"71,129.52","total_whole":"71,130","shares_owned_after":14158.0,"shares_owned_after_display":"14,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-27","filed_date":"2013-08-28","scope":"insider"},{"id":5306772,"accession":"0001209191-13-042231","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-042231","line_url":"/filing/0001209191-13-042231#line-1","is_derivative":false,"issuer_cik":"0001087432","issuer_name":"INTERMUNE INC","issuer_ticker":"ITMN","issuer_name_source":null,"issuer_url":"/issuer/0001087432","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1650.0,"shares_display":"1,650","price_per_share":14.9958,"price_display":"15.00","price_state":"stated","total_value":24743.07,"total_display":"24,743.07","total_whole":"24,743","shares_owned_after":9208.0,"shares_owned_after_display":"9,208","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-26","filed_date":"2013-08-28","scope":"insider"},{"id":4773747,"accession":"0001181431-13-035608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-035608","line_url":"/filing/0001181431-13-035608#line-1","is_derivative":false,"issuer_cik":"0000891288","issuer_name":"QUESTCOR PHARMACEUTICALS INC","issuer_ticker":"QCOR","issuer_name_source":null,"issuer_url":"/issuer/0000891288","owner_cik":"0001534002","owner_name":"Russell Angus C.","owner_display_name":"Russell Angus C.","owner_url":"/insider/0001534002","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3250.0,"shares_display":"3,250","price_per_share":46.1494,"price_display":"46.15","price_state":"stated","total_value":149985.55,"total_display":"149,985.55","total_whole":"149,986","shares_owned_after":8364.0,"shares_owned_after_display":"8,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479290","name":"Revance Therapeutics, Inc.","url":"/issuer/0001479290","role":"Director","n_filings":1,"first_seen":"2021-12-15","last_seen":"2021-12-15"},{"type":"issuer","type_label":"ISSUER","cik":"0000876343","name":"Lineage Cell Therapeutics, Inc.","url":"/issuer/0000876343","role":"Director","n_filings":2,"first_seen":"2015-11-10","last_seen":"2021-06-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001567892","name":"Mallinckrodt plc","url":"/issuer/0001567892","role":"Director","n_filings":1,"first_seen":"2020-11-16","last_seen":"2020-11-16"},{"type":"issuer","type_label":"ISSUER","cik":"0000025743","name":"TherapeuticsMD, Inc.","url":"/issuer/0000025743","role":"Director","n_filings":4,"first_seen":"2015-05-13","last_seen":"2019-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001087432","name":"INTERMUNE INC","url":"/issuer/0001087432","role":"Director","n_filings":1,"first_seen":"2013-08-28","last_seen":"2013-08-28"},{"type":"issuer","type_label":"ISSUER","cik":"0000891288","name":"QUESTCOR PHARMACEUTICALS INC","url":"/issuer/0000891288","role":"Director","n_filings":1,"first_seen":"2013-06-18","last_seen":"2013-06-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001534002","retrieved_at":"2026-08-24T14:21:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}